Time to Rethink PSA Screening—Reply
暂无分享,去创建一个
[1] R. DiPaola,et al. Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml. , 2010, Archives of internal medicine.
[2] D. Bostwick,et al. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] P. Scardino,et al. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] W. Catalona,et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. , 1995, JAMA.
[5] Hans Garmo,et al. Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer , 2011 .